IMC Chicago’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
92,126
+20,170
| +28% | +$338K | ﹤0.01% | 279 |
|
|
2025
Q1 | $1.11M | Buy |
+71,956
| New | +$1.11M | ﹤0.01% | 284 |
|
|
2024
Q4 | – | Sell |
-33,328
| Closed | -$601K | – | 1372 |
|
|
2024
Q3 | $601K | Sell |
33,328
-36,977
| -53% | -$666K | ﹤0.01% | 335 |
|
|
2024
Q2 | $1.14M | Buy |
70,305
+45,157
| +180% | +$734K | ﹤0.01% | 293 |
|
|
2024
Q1 | $355K | Buy |
+25,148
| New | +$355K | ﹤0.01% | 384 |
|
|
2023
Q4 | – | Sell |
-91,254
| Closed | -$931K | – | 810 |
|
|
2023
Q3 | $931K | Sell |
91,254
-41,676
| -31% | -$425K | ﹤0.01% | 134 |
|
|
2023
Q2 | $1M | Sell |
132,930
-96,919
| -42% | -$730K | ﹤0.01% | 93 |
|
|
2023
Q1 | $2.03M | Buy |
229,849
+125,574
| +120% | +$1.11M | ﹤0.01% | 41 |
|
|
2022
Q4 | $951K | Buy |
104,275
+27,762
| +36% | +$253K | ﹤0.01% | 90 |
|
|
2022
Q3 | $617K | Sell |
76,513
-110,485
| -59% | -$891K | ﹤0.01% | 149 |
|
|
2022
Q2 | $1.41M | Buy |
186,998
+56,245
| +43% | +$423K | ﹤0.01% | 94 |
|
|
2022
Q1 | $1.23M | Sell |
130,753
-110,134
| -46% | -$1.03M | ﹤0.01% | 138 |
|
|
2021
Q4 | $1.93M | Buy |
240,887
+130,638
| +118% | +$1.05M | ﹤0.01% | 125 |
|
|
2021
Q3 | $1.07M | Sell |
110,249
-21,428
| -16% | -$209K | ﹤0.01% | 153 |
|
|
2021
Q2 | $1.3M | Buy |
131,677
+49,265
| +60% | +$488K | ﹤0.01% | 109 |
|
|
2021
Q1 | $951K | Buy |
+82,412
| New | +$951K | ﹤0.01% | 141 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 478 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 458 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 442 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 430 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 412 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 365 |
|
|
2019
Q2 | – | Sell |
-22,168
| Closed | -$348K | – | 355 |
|
|
2019
Q1 | $348K | Buy |
+22,168
| New | +$348K | ﹤0.01% | 82 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 385 |
|